K2Vital, a branded vitamin K2 MK-7 from Kappa Bioscience was approved in China for use in children’s health and maternal milk powders, and approved as safe for use in Mexico
Photo © iStockphoto.com/shironosov
K2Vital, a branded vitamin K2 MK-7 from Kappa Bioscience (Oslo, Norway) was approved in China for use in children’s health and maternal milk powders, and approved as safe for use in Mexico, expanding the global footprint of vitamin K2. China’s approval of the ingredient represents the first Chinese approval of synthetically manufactured vitamin K2 MK-7. The approval also covers microencapsulated K2Vital Delta, a stability solution for products that include minerals.
“The approval of synthetically-produced K2 MK-7 in China validates the reasons for K2Vital market growth globally,” said Peter Wisler, distributor liaison for Kappa, in a press release. “What is really interesting is that it demonstrates how Asia is perhaps ahead of world markets in recognizing K2 for children’s health. K2-fortified beverages for children are common in markets like Vietnam where milk consumption is low. K2 plays an important role in bone growth in children, and powder and beverage formats increasingly used as a solution.”
In formulations, vitamin K2 is a natural complement to vitamin D3, and provides synergistic benefits to calcium, magnesium, and omega-3s to support bone and heart health.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
U.S. Hemp Authority announces Adult Use Hemp Product Certification Program
April 15th 2024The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”